MarketWatch · Aug 4, 2026 20:17 UTC Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame Read full story on MarketWatch Share AI disclosure Summary The Danish drugmaker also revealed an improved outlook for the year. Original reporting Open original source Read full article on MarketWatch Get the AFBytes Brief Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime. Subscribe
